(Q44762890)

6 December 2017

title

Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma (English)

1 reference

6 December 2017

Paul G Murray

1

1 reference

6 December 2017

Guo-Hua Qiu

2

1 reference

6 December 2017

Li Fu

3

1 reference

6 December 2017

Elyse R Waites

4

1 reference

6 December 2017

Gopesh Srivastava

5

1 reference

6 December 2017

Duncan Heys

6

1 reference

6 December 2017

Angelo Agathanggelou

7

1 reference

6 December 2017

Farida Latif

8

1 reference

6 December 2017

Richard G Grundy

9

1 reference

6 December 2017

Jillian R Mann

10

1 reference

6 December 2017

Jane Starczynski

11

1 reference

6 December 2017

John Crocker

12

1 reference

6 December 2017

Sheila E Parkes

13

1 reference

6 December 2017

Richard F Ambinder

14

1 reference

6 December 2017

Lawrence S Young

15

1 reference

6 December 2017

Qian Tao

16

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

23

1 reference

6 December 2017

issue

6

1 reference

6 December 2017

page(s)

1326-1331

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207313

6 December 2017

exact match

0 references

cites work

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

7 January 2021

RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

7 January 2021

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

7 January 2021

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

7 January 2021

Identification of a novel Ras-regulated proapoptotic pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

7 January 2021

The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

7 January 2021

A novel family of Ras-binding domains

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

7 January 2021

The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

7 January 2021

Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

7 January 2021

Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207313

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207313

1 reference

Dimensions Publication ID

6 December 2017

1033315601

0 references

1 reference